Phibro Animal Health (NASDAQ:PAHC) Cut to Buy at StockNews.com

StockNews.com cut shares of Phibro Animal Health (NASDAQ:PAHC) from a strong-buy rating to a buy rating in a report released on Friday.

PAHC has been the topic of a number of other research reports. Bank of America raised their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Barclays raised their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company.

Phibro Animal Health Stock Up 1.3 %

PAHC stock opened at $23.21 on Friday. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The stock has a market capitalization of $940.07 million, a P/E ratio of 53.98, a P/E/G ratio of 0.61 and a beta of 0.51. The business has a fifty day moving average price of $23.44 and a 200-day moving average price of $20.41.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s payout ratio is 111.63%.

Institutional Trading of Phibro Animal Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. CWM LLC boosted its stake in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the last quarter. nVerses Capital LLC purchased a new position in Phibro Animal Health during the third quarter valued at $70,000. Quantbot Technologies LP bought a new stake in Phibro Animal Health during the third quarter valued at about $70,000. Summit Securities Group LLC purchased a new stake in Phibro Animal Health in the second quarter worth about $83,000. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.